Clinical Trial

Survival Benefit of Compound Kushen Injection in the Treatment of Advanced Colorectal Cancer

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated December 27, 2024 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
To clarify the effectiveness and safety of compound kushen injection in the treatment of advanced colorectal cancer.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-06-07.
Trial Details
NCT Number NCT05894694
Lead Sponsor Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Conditions Advanced Colorectal Carcinoma
Enrollment 320 participants
Start Date 2023-09-27
Primary Completion 2025-12-30 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-12-27